Research Article
Validation of a Thin-Layer Chromatography for the Determination of Hydrocortisone Acetate and Lidocaine in a Pharmaceutical Preparation
Table 1
Experimental design matrix (23) for robustness test for biological active substances coming from injection dosage form of examined drug.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HA: hydrocortisone acetate; L: lidocaine hydrochloride. : sorbent type; : chamber type; : temperature of plate activation; : distance of development; : saturation time of the chamber; : volume of chloroform; : volume of acetone. |